Moderna Stock Prediction and Forecast [MRNA]

AI-generated source summary

The video presents a bearish technical analysis of MRNA, stating that since August 22nd, 2025, MRNA is considered a sell candidate, with a score of -3.06. It shows a 6.53% loss over two days. 3-month trend indicates a 4.22% change with a possible range of 4.22% to 44.72%. The 12-month analysis suggests a -52.07% change in price over the next year, and possible drop $5.69 to $18.76. The last trading day showed a 6.53% decline. It is mentioned that approval and sentiment may lift sentiment while weak guidance and policy create volatility. The analysts' consensus is SELL. It is suggested monitoring a potential BUY signal on 3-Month MACD. A long-term average suggests to sell the stock if it rises above $27.09 and $29.84, given the increased volume when prices decreased. Also, that there isn’t a strong level of support. All this points out to MRNA stock decreasing over the course of the next twelve months. A Stop-Loss wasn't able to be determined due to the bearish evaluation.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   26 Aug 2025, 03:20 UTC

   The analyst published the original source item.

2. First prediction resolved

   01 Oct 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   01 Oct 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:12 UTC

   Tahlil Plus began monitoring the extracted predictions.